NASDAQ: INCYIncyte Revenue
Incyte revenue was $4.58B for the trailing 12 months ending Jun 30, 2025, with 1,063.2% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $1.2B, up 15.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INCY annual revenue was $4.2B, with 14.8% growth year-over-year.
INCY past revenue growth
How has INCY's revenue growth performed historically?
Company
18.87%
Industry
1,617.25%
Market
37.62%
INCY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INCY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INCY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
INCY revenue history
Current Revenue
$4.6B
Current Earnings
$870.9M
Current Profit Margin
19%
INCY's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when INCY announces revenue.
INCY Revenue History By Year
| INCY Yearly Revenue | INCY Revenue | INCY Change | INCY Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $4.24B | $545.57M | +14.76% |
| 2023-12-31 | $3.70B | $301.01M | +8.87% |
| 2022-12-31 | $3.39B | $408.37M | +13.67% |
| 2021-12-31 | $2.99B | $319.57M | +11.98% |
| 2020-12-31 | $2.67B | $507.94M | +23.53% |
| 2019-12-31 | $2.16B | $276.88M | +14.71% |
| 2018-12-31 | $1.88B | $345.67M | +22.50% |
| 2017-12-31 | $1.54B | $430.50M | +38.93% |
| 2016-12-31 | $1.11B | $351.97M | +46.70% |
| 2015-12-31 | $753.75M | $242.26M | +47.36% |
| 2014-12-31 | $511.50M | $156.55M | +44.10% |
| 2013-12-31 | $354.95M | $57.89M | +19.49% |
| 2012-12-31 | $297.06M | $202.60M | +214.50% |
| 2011-12-31 | $94.46M | -$75.42M | -44.40% |
| 2010-12-31 | $169.88M | $160.61M | +1,733.55% |
| 2009-12-31 | $9.27M | $5.35M | +136.41% |
| 2008-12-31 | $3.92M | -$30.52M | -88.62% |
| 2007-12-31 | $34.44M | $6.80M | +24.59% |
| 2006-12-31 | $27.64M | $19.80M | +252.32% |
| 2005-12-31 | $7.85M | -$6.30M | -44.54% |
| 2004-12-31 | $14.15M | -$27.05M | -65.66% |
| 2003-12-31 | $41.20M | -$54.28M | -56.85% |
| 2002-12-31 | $95.47M | -$123.79M | -56.46% |
| 2001-12-31 | $219.26M | $25.10M | +12.92% |
| 2000-12-31 | $194.17M | $37.21M | +23.70% |
| 1999-12-31 | $156.96M | $22.15M | +16.43% |
| 1998-12-31 | $134.81M | $44.82M | +49.80% |
| 1997-12-31 | $90.00M | $48.10M | +114.81% |
| 1996-12-31 | $41.90M | $29.68M | +243.06% |
| 1995-12-31 | $12.21M | $10.70M | +707.67% |
| 1994-12-31 | $1.51M | N/A | N/A |
Incyte Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.